Home Your basket
• An original case of laryn...
   Price 8.50 €
• Acute mesenteric ischemia...
   Price 5.50 €
• Proposition of adaptation...
   Price 10.50 €
• A perceptual study of the...
   Price 8.50 €
• Combined approach (extern...
   Price 10.50 €
• Personal experience about...
   Price 10.50 €
• Objective tinnitus and es...
   Price 5.50 €
• The symphonix symposium u...
   Price 8.50 €
• Endoscopic sphenoid proce...
   Price 8.50 €
• External otitis...
   Price 8.50 €
• Acoustic recognition of e...
   Price 8.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Postural study on healthy...
   Price 10.50 €
• Nasal polyposis: long ter...
   Price 10.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Hearing aid : practical a...
   Price 10.50 €
• Interest of hypnotherapy ...
   Price 10.50 €
• Training strategies of th...
   Price 8.50 €
• Glomangioma or "glomic tu...
   Price 5.50 €
• Pharyngolaryngectomy for ...
   Price 10.50 €
• The effect of the speaker...
   Price 10.50 €
• Transit time of swallowin...
   Price 10.50 €
• A rare and unusual cause ...
   Price 8.50 €
• Why is allergic rhinitis ...
   Price 12.00 €
• Traditional and emerging ...
   Price 10.50 €
• Fibrous dysplasia, a case...
   Price 10.50 €
• Audiological comparison b...
   Price 14.00 €
• Utility of positron emiss...
   Price 8.50 €
• Early PTH assay after tot...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Congenital absence of the...
   Price 8.50 €
• Endoscopic endonasal surg...
   Price 8.50 €
• Larynx manipulation....
   Price 5.50 €
• Malignant melanoma of the...
   Price 10.50 €
• Esthesioneuroblastoma in ...
   Price 8.00 €
• Management of cervical ce...
   Price 10.50 €
• Impaired laryngeal mobili...
   Price 10.50 €
• Facial aesthetic lipostru...
   Price 10.50 €
• Pure sensorineural hearin...
   Price 5.50 €
• Tuberculous otomastoiditi...
   Price 5.50 €

Total Order 360.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2013 o

CANCER

MIF in Head and Neck cancer: A new therapeutic target?


Authors : Lechien JR, Kindt N, Costa de Araujo P, Preillon J, Chantrain G, Laurent G, Saussez S. (Mons)

Ref. : Rev Laryngol Otol Rhinol. 2013;134,2:67-74.

Article published in french
Downloadable PDF document french



Summary : Macrophage migration inhibitory factor is a critical pro-inflammatory cytokine produced by cells of innate and adaptive immune system. MIF plays a key role in cell cycle regulation and in the pathogenesis of many cancers. Recently, MIF has been studied in the upper aerodigestive tract cancer for its involvement in tumor progression, invasion, proliferation and cell motility. In addition, MIF appears to be a mediator in angiogenesis and in the development of metastasis and locoregional lymph node, which are often associated with a poor prognosis. The mechanisms of action responsible for MIF involvement in tumor progression are not completely eluci­da­ted. However, the main effects of MIF are mediated by the CD74 receptor. MIF binding to its receptor is responsible for the activation of several signaling pathways (ERK1 / 2 - MAPK, JAB1 - CSN5, PI3K - Akt), the inhibition of p53 and the stimu­la­tion of angiogenic factors including VEGF and IL-8. The overexpression of MIF also causes a reduction of the anti-tumor activity of the immune system. Finally, MIF could be an inte­res­ting biomarker in the diagnosis and monitoring of upper aero-digestive tract cancers. In this paper, we assess the state of knowledge of MIF involvement in upper aero-digestive tract cancers and we analyze the therapeutic perspectives.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE